Abstract
The development of the new ligand serotonin-5-O-carboxymethyl-glycyl [125I]tyrosinamide (abbreviated [125I]GTI) allows for the direct visualization of serotonin1B and serotonin1D (5-HT1B/1D) sites. Autoradiographic techniques were used to demonstrate the selective binding of this ligand to 5-HT1D sites in human post-mortem brain materials. The distribution of [125I]GTI binding sites was compared to [3H]5-HT sites in the presence of different displacers. The results show the selective binding of [125I]GTI to sites in the basal ganglia and substantia nigra which corresponds to 5-HT1D receptors.
| Original language | English |
|---|---|
| Pages (from-to) | 175-178 |
| Number of pages | 4 |
| Journal | Molecular Brain Research |
| Volume | 13 |
| Issue number | 1-2 |
| DOIs | |
| Publication status | Published - Mar 1992 |
| Externally published | Yes |
Keywords
- Globus pallidus
- Serotonin-5-O-carboxymethyl-glycyl[I]tyrosinamide
- Substantia nigra
- [H]Serotonin binding site
Fingerprint
Dive into the research topics of 'Direct visualization of serotonin1D receptors in the human brain using a new iodinated radioligand'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver